Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Protagenic Therapeutics Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH
Ticker
Exchange
SIC #
Website
Latest Ticker
PTIX
Nasdaq
8731
https://protagenic.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Protagenic Therapeutics Inc
Protagenic Therapeutics Successfully Concludes Third Cohort in Single Dose Portion of Phase 1 Trial for Stress-Related Neuropsychiatric Disorders
- Mar 27th, 2024 12:42 pm
Protagenic Therapeutics Schedules First Q4 and FY 2023 Earnings Call
- Mar 25th, 2024 9:00 pm
Protagenic Therapeutics Announces Resolution of Nasdaq Deficiency Notice
- Mar 21st, 2024 12:41 pm
Protagenic Therapeutics Achieves First Clinical Safety Milestone with its Novel Neuropeptide for the Potential Treatment of Stress-Related Disorders
- Feb 13th, 2024 1:30 pm
Protagenic Therapeutics Announces Date of Annual Shareholder Meeting
- Oct 13th, 2023 1:00 pm
Protagenic Therapeutics Initiates Phase I/IIa Clinical Trial for Groundbreaking Brain Peptide PT00114
- Sep 26th, 2023 12:18 pm
Scroll